Pharming Group (NASDAQ:PHAR) Shares Gap Up to $11.25

Pharming Group (NASDAQ:PHARGet Rating) shares gapped up before the market opened on Wednesday . The stock had previously closed at $11.25, but opened at $11.75. Pharming Group shares last traded at $11.25, with a volume of 2,199 shares.

Analyst Upgrades and Downgrades

Separately, TheStreet upgraded shares of Pharming Group from a “d+” rating to a “c” rating in a report on Monday, August 15th.

Pharming Group Stock Down 8.2 %

The company has a quick ratio of 4.53, a current ratio of 5.22 and a debt-to-equity ratio of 0.64. The business’s fifty day simple moving average is $10.40 and its 200 day simple moving average is $8.95.

About Pharming Group

(Get Rating)

Pharming Group N.V., a biopharmaceutical company, develops and commercialize protein replacement therapies and precision medicines for the treatment of rare diseases and unmet medical needs in the United States, Europe, and internationally. The company's lead product is Ruconest, a recombinant human C1 esterase inhibitor that is used for the treatment of acute hereditary angioedema.

Recommended Stories

Receive News & Ratings for Pharming Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pharming Group and related companies with MarketBeat.com's FREE daily email newsletter.